Method for treating phthisis by inhaling atomized purple garlic liquid

Abstract

The invention belongs to the technical field of medicine, and relates to a method for treating the phthisis and the respiratory disease by inhaling atomized purple garlic liquid, in particular to a method for treating the phthisis through the extracting solution of purple garlic (the purple garlic liquid) and an atomizer. The purple garlic liquid is extracted at the low temperature and is atomized by the atomizer into ultramicro particles with the diameter being about 0.2 micron, the atomized liquid can fully and evenly adhere to the pulmonary alveoli and the inner walls of the bronchi through the deep breathing and medicine feeding treatment, and due to the fact that the diameter of the atomized liquid is small, the atomized liquid permeates evenly and can reach the focal zone to carry out sterilization and take part in the lung blood microcirculation, and the active ingredient allisatin of the garlic liquid is conveyed along with the blood to kill and restrain bacteria. The method solves the problems that current common oral administration anti-phthisis western medicines are large in side effect and bad in medicine resistance and curative effect and injure the liver and kidneys. The method can be applied to the pneumology department to treat bronchitis, asthma, flu, sphagitis, rhinitis, nasosinusitis and other respiratory diseases besides the phthisis and pneumonia in the pulmonary medicine. The purple garlic liquid is a very good natural medicine, and the method is very good.

Description

technical field [0001] The invention relates to a method for inhaling atomized purple-skinned garlic extract by using an atomizing inhaler to treat tuberculosis and respiratory diseases. Background technique [0002] At present, the number of people infected with tuberculosis in my country is the largest in history, and it is also one of the most serious disaster areas in the world. According to the statistics of the World Health Organization, my country is one of the 22 countries with a high incidence of tuberculosis in the world, and it is also one of the 27 countries with severe MDR-TB epidemics in the world. The number of patients ranks second in the world. At present, the number of tuberculosis infections in my country is about 550 million, that is to say, nearly half of the people are tuberculosis carriers, and there is a huge demand for treatment. Currently, there are five commonly used anti-tuberculosis drugs in China: isoniazid, rifampicin, pyrazinamide, ethambutol...

AI Technical Summary

Problems solved by technology

Tuberculosis bacteria are prone to mutation, so it is easy to cause single-structure chemical drugs to fail quickly and produce drug resistance. Even if they are not drug-resistant for a certain period of time, the side effects of these drugs on liver, kidney and other organs are increasing after long-term oral administration. It is unbearable, and it is easy to relapse after stopping the drug; it hurts the body and does not heal well